GDC-0941, a novel class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivo (Q42506399)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | GDC-0941, a novel class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivo |
scientific article |
Statements
1 reference
GDC-0941, a novel class I selective PI3K inhibitor, enhances the efficacy of docetaxel in human breast cancer models by increasing cell death in vitro and in vivo (English)
1 reference
Jeffrey J Wallin
1 reference
Jane Guan
1 reference
Wei Wei Prior
1 reference
Leslie B Lee
1 reference
Leanne Berry
1 reference
Lisa D Belmont
1 reference
Hartmut Koeppen
1 reference
Marcia Belvin
1 reference
Lori S Friedman
1 reference
Deepak Sampath
1 reference
14 May 2012
1 reference
1 reference
18
1 reference
14
1 reference
3901-3911
1 reference
Identifiers
1 reference
1 reference